Clinical Pharmacology Study of MP-424
NCT01766167
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
26
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Hepatitis C
Interventions
DRUG:
MP-424
DRUG:
MP-424
DRUG:
MP-424
DRUG:
MP-424
Sponsor
Tanabe Pharma Corporation